Thyrocare Technologies Ltd (THYROCARE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1000893,
    "name": "Thyrocare Tech.",
    "stock_name": "Thyrocare Tech.",
    "full_name": "Thyrocare Technologies Ltd",
    "name_url": "stocks-analysis/thyrocare-tech",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "424.55",
    "chg": -34.15,
    "chgp": "-7.44%",
    "dir": -1,
    "prev_price": "458.70",
    "mcapval": "7,040.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539871,
    "symbol": "THYROCARE",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE594H01019",
    "curr_date": "Jan 29",
    "curr_time": "",
    "bse_nse_vol": "10.83 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 29, 2026",
    "traded_date_str": "2026 01 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/thyrocare-tech-1000893-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Thyrocare Technologies Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-thyrocare-technologies-ltd-latest-results-good-or-bad-3810099",
        "imagepath": "",
        "date": "2026-01-29 19:23:10",
        "description": "Thyrocare Technologies Ltd's latest financial results for Q3 FY26 indicate a notable performance, characterized by significant operational growth and efficiency. The company reported a net profit of ₹47.99 crores, reflecting a substantial year-on-year increase of 79.94%. This growth was supported by a revenue increase of 22.09%, reaching ₹216.53 crores, which also demonstrated robust sequential momentum with a 12.17% rise compared to the previous quarter.\n\nThe operational metrics highlight an operating margin of 32.95%, which is a marked improvement from the prior year's 27.23%, showcasing effective cost management and enhanced asset utilization. Additionally, the profit after tax margin improved significantly to 22.08%, up from 14.90% in the same quarter last year, indicating better earnings quality driven by operational efficiency and a normalized tax rate.\n\nOn a half-yearly basis, Thyrocare's consolidate..."
      },
      {
        "title": "Thyrocare Technologies Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-hits-intraday-low-amid-price-pressure-3809512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_priceRelatedfactors_3809512.png",
        "date": "2026-01-29 11:01:30",
        "description": "Thyrocare Technologies Ltd experienced a notable decline today, hitting an intraday low of Rs 428, down 6.79% from its previous close, reflecting significant price pressure amid a broadly negative market environment."
      },
      {
        "title": "Thyrocare Technologies Q3 FY26: Stellar Profit Surge Masks Premium Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/thyrocare-technologies-q3-fy26-stellar-profit-surge-masks-premium-valuation-concerns-3808291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_quaterlyResult_3808291.png",
        "date": "2026-01-28 19:02:44",
        "description": "Thyrocare Technologies Ltd., the Mumbai-based diagnostic services provider, delivered a blockbuster performance in Q3 FY26, with consolidated net profit surging 79.94% year-on-year to ₹47.99 crores, substantially outpacing market expectations. The company's shares, trading at ₹459.00 with a market capitalisation of ₹7,197 crores, have gained 81.97% over the past year, dramatically outperforming both the Sensex and the broader healthcare services sector. However, this stellar operational momentum comes at a steep price, with the stock commanding a premium valuation of 57 times trailing earnings and trading at 13.68 times book value, raising questions about whether current levels adequately factor in future growth prospects."
      },
      {
        "title": "Thyrocare Technologies Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/thyrocare-technologies-ltd-is-rated-buy-3804007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_mojoScore_3804007.png",
        "date": "2026-01-25 10:10:30",
        "description": "Thyrocare Technologies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 Nov 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Thyrocare Technologies Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-sees-mixed-technical-signals-amid-mild-momentum-shift-3799527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_technicaldot_3799527.png",
        "date": "2026-01-22 08:01:38",
        "description": "Thyrocare Technologies Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late January 2026. Despite a recent day decline of 3.13%, the stock’s broader technical indicators and price action suggest a cautiously optimistic outlook, supported by mixed signals from key momentum oscillators and moving averages. This analysis delves into the evolving technical landscape of Thyrocare, contextualising its performance against sector peers and the broader market."
      },
      {
        "title": "When is the next results date for Thyrocare Technologies Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-thyrocare-technologies-ltd-3799049",
        "imagepath": "",
        "date": "2026-01-21 23:16:28",
        "description": "The next results date for Thyrocare Technologies Ltd is scheduled for 28 January 2026...."
      },
      {
        "title": "Thyrocare Technologies Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-3797710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_technicaldot_3797710.png",
        "date": "2026-01-21 08:04:04",
        "description": "Thyrocare Technologies Ltd has exhibited a notable shift in its technical momentum, transitioning from a mildly bullish to a bullish trend, supported by a confluence of key indicators such as MACD, RSI, moving averages, and Bollinger Bands. This technical evolution, coupled with strong long-term returns relative to the Sensex, underscores a positive outlook for the healthcare services company as it navigates the current market environment."
      },
      {
        "title": "Thyrocare Technologies Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-3793756",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_technicaldot_3793756.png",
        "date": "2026-01-19 08:03:12",
        "description": "Thyrocare Technologies Ltd has experienced a subtle shift in its price momentum, transitioning from a bullish to a mildly bullish technical trend. Despite a slight dip in the daily price, the stock’s broader technical indicators present a nuanced picture, reflecting mixed signals across key metrics such as MACD, RSI, and moving averages. This development invites a closer examination of the stock’s technical health and its implications for investors in the healthcare services sector."
      },
      {
        "title": "Thyrocare Technologies Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/thyrocare-technologies-ltd-is-rated-buy-3791952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_mojoScore_3791952.png",
        "date": "2026-01-14 10:10:04",
        "description": "Thyrocare Technologies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      }
    ],
    "total": 283,
    "sid": "1000893",
    "stock_news_url": "https://www.marketsmojo.com/news/thyrocare-technologies-1000893"
  },
  "announcements": [
    {
      "details": "Thyrocare Technologies Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates.",
      "source": "NSE",
      "caption": "Thyrocare Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Thyrocare Technologies Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Thyrocare Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Thyrocare Technologies Limited has informed the Exchange that Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended the Company has submitted to the Exchange a copy of Disclosure of Related Party Transactions during the half year ended on September 30, 2019 on a consolidated basis.",
      "source": "NSE",
      "caption": "Thyrocare Technologies Limited - Other General Purpose",
      "datetime": "21-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Thyrocare Technologies Ltd has declared <strong>70%</strong> dividend, ex-date: 24 Oct 25",
          "dt": "2025-10-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Thyrocare Technologies Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 28 Nov 25",
          "dt": "2025-11-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Thyrocare Technologies Ltd latest results good or bad?

2026-01-29 19:23:10

Thyrocare Technologies Ltd's latest financial results for Q3 FY26 indicate a notable performance, characterized by significant operational growth and efficiency. The company reported a net profit of ₹47.99 crores, reflecting a substantial year-on-year increase of 79.94%. This growth was supported by a revenue increase of 22.09%, reaching ₹216.53 crores, which also demonstrated robust sequential momentum with a 12.17% rise compared to the previous quarter. The operational metrics highlight an operating margin of 32.95%, which is a marked improvement from the prior year's 27.23%, showcasing effective cost management and enhanced asset utilization. Additionally, the profit after tax margin improved significantly to 22.08%, up from 14.90% in the same quarter last year, indicating better earnings quality driven by operational efficiency and a normalized tax rate. On a half-yearly basis, Thyrocare's consolidate...

Read full news article

Thyrocare Technologies Ltd Hits Intraday Low Amid Price Pressure

2026-01-29 11:01:30

Thyrocare Technologies Ltd experienced a notable decline today, hitting an intraday low of Rs 428, down 6.79% from its previous close, reflecting significant price pressure amid a broadly negative market environment.

Read full news article

Thyrocare Technologies Q3 FY26: Stellar Profit Surge Masks Premium Valuation Concerns

2026-01-28 19:02:44

Thyrocare Technologies Ltd., the Mumbai-based diagnostic services provider, delivered a blockbuster performance in Q3 FY26, with consolidated net profit surging 79.94% year-on-year to ₹47.99 crores, substantially outpacing market expectations. The company's shares, trading at ₹459.00 with a market capitalisation of ₹7,197 crores, have gained 81.97% over the past year, dramatically outperforming both the Sensex and the broader healthcare services sector. However, this stellar operational momentum comes at a steep price, with the stock commanding a premium valuation of 57 times trailing earnings and trading at 13.68 times book value, raising questions about whether current levels adequately factor in future growth prospects.

Read full news article

Thyrocare Technologies Ltd is Rated Buy

2026-01-25 10:10:30

Thyrocare Technologies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 Nov 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Thyrocare Technologies Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift

2026-01-22 08:01:38

Thyrocare Technologies Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late January 2026. Despite a recent day decline of 3.13%, the stock’s broader technical indicators and price action suggest a cautiously optimistic outlook, supported by mixed signals from key momentum oscillators and moving averages. This analysis delves into the evolving technical landscape of Thyrocare, contextualising its performance against sector peers and the broader market.

Read full news article

When is the next results date for Thyrocare Technologies Ltd?

2026-01-21 23:16:28

The next results date for Thyrocare Technologies Ltd is scheduled for 28 January 2026....

Read full news article

Thyrocare Technologies Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

2026-01-21 08:04:04

Thyrocare Technologies Ltd has exhibited a notable shift in its technical momentum, transitioning from a mildly bullish to a bullish trend, supported by a confluence of key indicators such as MACD, RSI, moving averages, and Bollinger Bands. This technical evolution, coupled with strong long-term returns relative to the Sensex, underscores a positive outlook for the healthcare services company as it navigates the current market environment.

Read full news article

Thyrocare Technologies Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-19 08:03:12

Thyrocare Technologies Ltd has experienced a subtle shift in its price momentum, transitioning from a bullish to a mildly bullish technical trend. Despite a slight dip in the daily price, the stock’s broader technical indicators present a nuanced picture, reflecting mixed signals across key metrics such as MACD, RSI, and moving averages. This development invites a closer examination of the stock’s technical health and its implications for investors in the healthcare services sector.

Read full news article

Thyrocare Technologies Ltd is Rated Buy

2026-01-14 10:10:04

Thyrocare Technologies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

View All News